House of Delegates today passed the Endocrine Society's resolution to improve access to anti-obesity medications.

The AMA passed a resolution to increase access to anti-obesity medications at its annual House of Delegates meeting.The resolution was championed by the Endocrine Society, according to a press release ...

Researchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in ...

Pursuing the worthy goal of reforming drug pricing requires a more radical change to the pharmaceutical industry.

Thousands of New York residents are waiting for a kidney transplant, and a long-delayed state program could soon spur more ...

Leaders of hundreds of public healthcare companies are in South Florida this week, talking up their innovations and financial ...

A new study published in the journal of BMC Nephrology revealed that kidney disease (KD) caused by an infection with the ...

Obesity is a structural health crisis, disproportionately affecting Black and Brown communities in California. Proposed budget cuts threaten access to effective treatments.

North Carolinians participating in the state Medicaid program will qualify — beginning Aug. 1 — for coverage of Food and Drug Administration-approved obesity management medications. Eligible ...

Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or ...

A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight ...

Gov. Josh Shapiro’s administration plans to save money by cutting poor patients’ access to expensive weight-loss drugs like ...